Mary Hanson, OT/L | |
43 Starr Farm Rd, Burlington, VT 05408-1321 | |
(802) 419-2421 | |
Not Available |
Full Name | Mary Hanson |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 43 Starr Farm Rd, Burlington, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033692470 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 072.0000084 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mary Hanson, OT/L 43 Starr Farm Rd, Burlington, VT 05408-1321 Ph: (802) 419-2421 | Mary Hanson, OT/L 43 Starr Farm Rd, Burlington, VT 05408-1321 Ph: (802) 419-2421 |
News Archive
MSD announced today that the European Commission has approved the Marketing Authorization Application (MAA) for SYCREST® (asenapine) sublingual tablets for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. Today's decision was based on recommendations from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP). The Commission Decision applies to all 27 European Member States.
The U.S. Food and Drug Administration's approval of Alkermes' opioid dependence medication (VIVITROL) for the prevention of relapse to opioid dependence following opioid detoxification is positive news for families of young adults and all those who are struggling to overcome opioid addiction. Addiction, a disease of the human brain, is a chronic illness while opioid dependence is frequently characterized by relapse.
According to information in the article, the prevalence of obesity in the United States increased from 12 percent in 1991 to 18 percent in 1998. Recent survey data indicate that 65 percent of Americans are overweight.
A machine learning algorithm developed by the Oxford Vaccine Group promises more effective vaccine development for several diseases, including COVID-19.
Developed and approved by the American College of Gastroenterology, these guidelines summarize advances in gastroesophageal reflux disease (GERD) diagnostic testing and how they have modified the clinical management of esophageal disorders.
› Verified 2 days ago
Po Jung Pan, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2450 | |
Mckenzie Jo Hartman-mattson, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 218-235-9355 | |
Kylie Stevenson-lyon, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-1000 | |
Sara Degaetano, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Sheperdson 2, Burlington, VT 05401 Phone: 802-847-2450 | |
Alyssa Morgan Smith, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Clara Shealy, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 |